199 related articles for article (PubMed ID: 24286961)
1. The evolution of coronary stents: a brief review.
Simard T; Hibbert B; Ramirez FD; Froeschl M; Chen YX; O'Brien ER
Can J Cardiol; 2014 Jan; 30(1):35-45. PubMed ID: 24286961
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
3. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Newsome LT; Kutcher MA; Royster RL
Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
[TBL] [Abstract][Full Text] [Related]
4. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of vascular response to drug-eluting stents: an insight from human autopsy into daily practice.
Nakano M; Virmani R
Cardiovasc Interv Ther; 2015 Jan; 30(1):1-11. PubMed ID: 25074761
[TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
8. Coronary Stents: The Impact of Technological Advances on Clinical Outcomes.
Mennuni MG; Pagnotta PA; Stefanini GG
Ann Biomed Eng; 2016 Feb; 44(2):488-96. PubMed ID: 26265457
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention: balloons, stents and scaffolds.
Colleran R; Kastrati A
Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of coronary artery restenosis.
Schwartz RS; Henry TD
Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
[TBL] [Abstract][Full Text] [Related]
11. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside.
Nicolas J; Pivato CA; Chiarito M; Beerkens F; Cao D; Mehran R
Cardiovasc Res; 2023 May; 119(3):631-646. PubMed ID: 35788828
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of in-stent restenosis and the potential benefit of drug eluting stents.
Froeschl M; Olsen S; Ma X; O'Brien ER
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Mar; 4(1):103-17. PubMed ID: 15032655
[TBL] [Abstract][Full Text] [Related]
13. Current status of the Xience V® everolimus-eluting coronary stent system.
Claessen BE; Caixeta A; Henriques JP; Piek JJ
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1363-74. PubMed ID: 20936921
[TBL] [Abstract][Full Text] [Related]
14. Newly available and recent advances in drug-eluting stents.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Giannini F; Colombo A
Expert Rev Cardiovasc Ther; 2013 May; 11(5):555-66. PubMed ID: 23621138
[TBL] [Abstract][Full Text] [Related]
15. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
Pendyala L; Jabara R; Robinson K; Chronos N
J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
[TBL] [Abstract][Full Text] [Related]
16. Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
Almalla M; Schröder JW; Pross V; Marx N; Hoffmann R
Coron Artery Dis; 2013 Mar; 24(2):165-70. PubMed ID: 23242011
[TBL] [Abstract][Full Text] [Related]
17. Stent thrombosis in the era of drug eluting stents.
Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
[TBL] [Abstract][Full Text] [Related]
19. Therapy insight: diabetes and drug-eluting stents.
Legrand V
Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):143-50. PubMed ID: 17330126
[TBL] [Abstract][Full Text] [Related]
20. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
